Access to Investigational Medicines

What are clinical trials?

• Clinical trials are research studies that test new medicines or treatments to determine safety and effectiveness.
• They run in phases and help develop new medicines for patients who need them.
• Participation is voluntary and is designed to protect patient safety and rights.

How patients can access investigational medicines

1. Join a clinical trial

• Patients may receive investigational medicines as part of a Bayer‑sponsored research study.
• Trials have specific eligibility criteria and study procedures; talk to your doctor to learn whether a suitable trial exists.

2. Single‑patient access (compassionate use)

• Patients may receive investigational medicines as part of a Bayer‑sponsored research study.
• In rare cases where no approved treatments are available or effective, a doctor can request access to an investigational medicine for a patient with a severe or life‑threatening condition.
• These requests are carefully reviewed to ensure safety and legal compliance.
• Doctors must make the request; patients cannot apply directly.

What to expect

• Decisions prioritize patient safety and confidentiality.
• Each request or trial participation follows strict review and oversight procedures.
• Bayer responds to physician requests and maintains patient privacy throughout the process.

Find a trial

• Use the Bayer Clinical Trials Finder to search for recruiting trials by condition, view study details, and learn about participation criteria.
• If you’re interested, speak with your doctor to review eligibility and next steps.

Key takeaways

• Investigational medicines = not yet approved.
• Two access routes: clinical trials or doctor‑requested single‑patient access.
• Doctors must request single‑patient access; patients cannot apply directly.
• For trial searches and details, use the Bayer Clinical Trials Finder